Trial Profile

First-in-human trial of COVID-19 vaccine

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 23 Sep 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs COVID 19 vaccine Axon Neuroscience (Primary)
Indications COVID 2019 infections
Focus Adverse reactions; First in man
Sponsors Axon Neuroscience

Most Recent Events

18 Sep 2020 According to an Axon Neuroscience media release, the company plans to begin first-in-human trials as early as the fourth quarter of 2020.
16 Apr 2020 New trial record
09 Apr 2020 According to an Axon Neuroscience media release, Given the expedited regulatory procedures for COVID-19, the first-in-human administration with our vaccine could take place as early as September 2020, much quicker than standard vaccine timelines

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com